Azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene as 5-HT1A antagonists
申请人:Wyeth
公开号:US20020193365A1
公开(公告)日:2002-12-19
Compounds of the formula
1
are useful for treating the cognitive deficits due to aging, stroke, head trauma, Alzheimer's disease or other neurodegenerative diseases, or schizophrenia. The compounds of the invention are also useful for the treatment of disorders such as anxiety, aggression and stress, and for the control of various physiological phenomena, such as appetite, thermoregulation, sleep and sexual behavior.
公式1的化合物可用于治疗因衰老、中风、头部创伤、阿尔茨海默病或其他神经退行性疾病或精神分裂症引起的认知缺陷。本发明的化合物还可用于治疗焦虑、攻击性和压力等疾病,并用于控制各种生理现象,例如食欲、体温调节、睡眠和性行为。